- Home
- ENTA vs VOXX Comparison
ENTA vs VOXX Comparison
Compare ENTA & VOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- VOXX
- Stock Information
- Founded
- ENTA 1995
- VOXX 1960
- Country
- ENTA United States
- VOXX United States
- Employees
- ENTA N/A
- VOXX 911
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- VOXX Electronic Components
- Sector
- ENTA Health Care
- VOXX Technology
- Exchange
- ENTA Nasdaq
- VOXX Nasdaq
- Market Cap
- ENTA 154.0M
- VOXX 169.1M
- IPO Year
- ENTA 2013
- VOXX 1987
- Fundamental
- Price
- ENTA $5.32
- VOXX $7.50
- Analyst Decision
- ENTA Buy
- VOXX
- Analyst Count
- ENTA 4
- VOXX 0
- Target Price
- ENTA $17.25
- VOXX N/A
- AVG Volume (30 Days)
- ENTA 233.9K
- VOXX 186.8K
- Earning Date
- ENTA 05-05-2025
- VOXX 05-13-2025
- Dividend Yield
- ENTA N/A
- VOXX N/A
- EPS Growth
- ENTA N/A
- VOXX N/A
- EPS
- ENTA N/A
- VOXX N/A
- Revenue
- ENTA $66,590,999.00
- VOXX $397,407,000.00
- Revenue This Year
- ENTA N/A
- VOXX $7.88
- Revenue Next Year
- ENTA N/A
- VOXX $7.24
- P/E Ratio
- ENTA N/A
- VOXX N/A
- Revenue Growth
- ENTA N/A
- VOXX N/A
- 52 Week Low
- ENTA $4.71
- VOXX $2.27
- 52 Week High
- ENTA $17.60
- VOXX $8.40
- Technical
- Relative Strength Index (RSI)
- ENTA 30.35
- VOXX 63.13
- Support Level
- ENTA $5.65
- VOXX $7.43
- Resistance Level
- ENTA $5.96
- VOXX $7.51
- Average True Range (ATR)
- ENTA 0.36
- VOXX 0.02
- MACD
- ENTA -0.15
- VOXX -0.00
- Stochastic Oscillator
- ENTA 2.95
- VOXX 83.33
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About VOXX VOXX International Corporation
VOXX International Corp manufacturer and distributor in the Automotive Electronics, Consumer Electronics, and Biometrics industries. The consumer electronic products primarily consist of finished goods sold to retail and commercial customers, consisting of premium audio and other consumer electronic products. Automotive products, some of which are manufactured by the Company, are sold both to OEM and aftermarket customers. Biometric products, primarily consisting of finished goods, are sold to retail and commercial customers.